SCHEMBL24309902

SCHEMBL24309902

COc1c(Oc2ccc(N3CCNCC3)cc2)nc(NSc2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.37
▸ LTA4H P09960 1/20 0.36
▸ HTR3E A5X5Y0 1/20 0.35
▸ HTR3B O95264 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ HTR3A P46098 1/20 0.35
▸ HTR3D Q70Z44 1/20 0.35
▸ HTR3C Q8WXA8 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ ACVR1 Q04771 8/20 0.35
▸ TGFBR1 P36897 7/20 0.35
▸ BMPR1A P36894 2/20 0.35
▸ ACVRL1 P37023 2/20 0.35
▸ RIPK2 O43353 2/20 0.35
▸ BMPR1B O00238 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ ACVR1B P36896 1/20 0.34
▸ DDR1 Q08345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309744 0.91 LTA4H (0.38) IGF1RLTA4HHTR3EHTR3BADRB1
SCHEMBL24309903 0.84 NOD2 (0.39) IGF1RLTA4HACVR1RIPK2LCK
SCHEMBL29566801 0.84 NOD2 (0.39) IGF1RLTA4HACVR1RIPK2LCK
SCHEMBL24309392 0.84 BRD4 (0.37) IGF1RJAK3TNK2
SCHEMBL24309676 0.83 FLT3 (0.38) IGF1RLTA4HACVR1TGFBR1BMPR1A
SCHEMBL24310025 0.82 TNK2 (0.35) IGF1RLTA4HACVR1LCKJAK3
SCHEMBL24310428 0.82 MAP4K1 (0.38) IGF1RJAK3TNK2
SCHEMBL24310424 0.82 PDE2A (0.41) IGF1RJAK3
SCHEMBL24310158 0.81 MAP4K1 (0.37) IGF1RJAK3TNK2
SCHEMBL24309719 0.80 MAP4K1 (0.37) IGF1RJAK3TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback